Circulating Pancreatic Polypeptide in Patients with Adenocarcinoma of the Bile Duct

Authors

  • Howard W. Bruckner Department of Neoplastic, Diseases and Derald Ruttenberg Cancer Center, NY, USA
  • Margaret R. Chesser Department of Neoplastic, Diseases and Derald Ruttenberg Cancer Center, NY, USA
  • John Mandeli Biomathematical Sciences, NY, USA
  • Leonard A. Farber Medical Student Fellowship ProgramMount Sinai Medical Center, New York, NY, USA
  • Giuseppe Digiovanni Medical Student Fellowship ProgramMount Sinai Medical Center, New York, NY, USA

DOI:

https://doi.org/10.3109/02841869309092442

Abstract

Using radioimmunoassay methods, the blood of patients with pancreatic tumors was screened for circulating polypeptide hormones. This screening discovered pancreatic polypeptide in abnormally high concentration in the serum of six of seven patients with adenocarcinomas of the bile duct. the assay appears to be very sensitive finding excessive residual pancreatic polypeptide production after palliative resections. Serum pancreatic polypeptide assays warrant evaluation as an aid in the diagnosis and management of patients with bile duct tumors.

Downloads

Download data is not yet available.

Downloads

Published

1993-01-01

How to Cite

Bruckner, H. W. ., Chesser, M. R., Mandeli, J., Farber, L. A. ., & Digiovanni, G. . (1993). Circulating Pancreatic Polypeptide in Patients with Adenocarcinoma of the Bile Duct. Acta Oncologica, 32(6), 627–629. https://doi.org/10.3109/02841869309092442

Issue

Vol. 32 No. 6 (1993): Acta Oncologica

Section

Articles